SCHEMBL21363791

SCHEMBL21363791

C=CCc1cc2c(cc1N)OCO2

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.53
MAPT P10636 2/20 0.53
CYP1A2 P05177 1/20 0.53
POLB P06746 3/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
MCL1 Q07820 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALOX15 P16050 1/20 0.39
GABRA1 P14867 1/20 0.36
GABRB2 P47870 1/20 0.36
CYP19A1 P11511 2/20 0.36
TAAR1 Q96RJ0 1/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
SLC6A4 P31645 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6423969 0.79 GABRA1 (0.41) CYP3A4MAPTCYP1A2POLBMEN1
SCHEMBL1276635 0.78 CYP3A4 (0.55) CYP3A4MAPTCYP1A2POLBMEN1
SCHEMBL21591954 0.78 MAPT (0.44) CYP3A4MAPTCYP1A2POLBMEN1
SCHEMBL7797624 0.77 CYP3A4 (0.53) CYP3A4MAPTCYP1A2POLBALDH1A1
SCHEMBL11696893 0.77 CYP3A4 (0.53) CYP3A4MAPTCYP1A2POLBMEN1
SCHEMBL3262914 0.77 GABRA1 (0.40) CYP3A4MAPTCYP1A2POLBMEN1
SCHEMBL13754293 0.74 MAPT (0.48) CYP3A4MAPTPOLBMEN1KMT2A
SCHEMBL5460784 0.74 MEN1 (0.44) CYP3A4MAPTPOLBMEN1KMT2A
SCHEMBL546296 0.73 MAPT (0.56) CYP3A4MAPTPOLBMEN1KMT2A
SCHEMBL29415600 0.73 MAPT (0.56) CYP3A4MAPTPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019175712-A1 NEW USES FOR CATECHOL MOLECULES AS INHIBITORS TO GLUTATHIONE S-TRANSFERASE METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed
WO-2019175713-A1 NEW CATECHOL MOLECULES AND THEIR USE AS INHIBITORS TO P450 RELATED METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed